MTHRF(MTHRF)
MTHRF
No analyst ratings available
No analyst price targets available for MTHRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $395.19B | $431.11B | $470.33B | $522.22B | $594.85B |
| Low | $380.61B | $409.34B | $449.64B | $499.24B | $568.68B |
| High | $408.16B | $448.10B | $487.38B | $541.15B | $616.42B |
| EBITDA Avg | $128.92B | $140.64B | $153.44B | $170.36B | $194.06B |
| Low | $124.17B | $133.54B | $146.69B | $162.87B | $185.52B |
| High | $133.16B | $146.19B | $159.00B | $176.54B | $201.09B |
| EBIT Avg | $117.65B | $128.34B | $140.02B | $155.46B | $177.09B |
| Low | $113.31B | $121.86B | $133.86B | $148.63B | $169.30B |
| High | $121.51B | $133.40B | $145.09B | $161.10B | $183.51B |
| Net Income Avg | $53.80B | $59.98B | $66.58B | $79.48B | $95.88B |
| Low | $50.72B | $56.55B | $62.77B | $74.93B | $90.40B |
| High | $56.34B | $62.81B | $69.72B | $83.22B | $100.40B |
| EPS Avg | $79.45 | $88.58 | $98.31 | $117.36 | $141.58 |
| Low | $74.90 | $83.51 | $92.69 | $110.65 | $133.49 |
| High | $83.19 | $92.75 | $102.95 | $122.89 | $148.26 |
| Analysts (Rev / EPS) | 13 / 1 | 13 / 1 | 8 / 1 | 11 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $94.19B | $105.57B | $99.64B |
| Low | $92.29B | $100.88B | $96.35B |
| High | $97.11B | $112.78B | $104.69B |
| EBITDA Avg | $30.73B | $34.44B | $32.50B |
| Low | $30.11B | $32.91B | $31.43B |
| High | $31.68B | $36.79B | $34.15B |
| EBIT Avg | $28.04B | $31.43B | $29.66B |
| Low | $27.47B | $30.03B | $28.68B |
| High | $28.91B | $33.57B | $31.17B |
| Net Income Avg | $12.74B | $15.92B | $13.58B |
| Low | $12.19B | $15.24B | $13.00B |
| High | $13.58B | $16.97B | $14.48B |
| EPS Avg | $19.08 | $23.85 | $20.34 |
| Low | $18.26 | $22.82 | $19.47 |
| High | $20.34 | $25.42 | $21.68 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 3 / 1 |